Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

May 06, 2020

Vaccine maker Pfizer and German pharmaceutical BioNTech will have a COVID-19 vaccine ready to go “in the millions” by the end of 2020, according to a press release.

The two companies are already in Phase 1 and Phase 2 clinical trials — with a grand total of 12 volunteers. The companies said they will enter a 200-subject trial soon, of people ages 18 to 55. When asked about the lightning speed at which the vaccines are being developed, National Vaccine Information Center co-founder and president Barbara Loe Fisher said, "Our organization is very concerned about fast-tracking the vaccine without proper study. We are worried that corners will be cut and the proper human and animal tests won’t be carried out."

SOURCE: The Vaccine Reaction May 3, 2020

Revolutionary Forum: Transforming Your Health Information Experience

Exciting news! We're thrilled to announce the development of a cutting-edge forum that will revolutionize how you engage with health information online. This major upgrade to our content management system will provide you with one of the best-in-class forums on the internet, designed to exceed all current offerings and transform your experience.

Our new forum will feature a dedicated health community section, allowing for more meaningful interactions and ensuring your questions are properly addressed—a significant improvement over our previous model. While we understand that the temporary removal of comments may be disappointing, we assure you that this change paves the way for a far superior platform.

This transformative project is on track for a future launch. We appreciate your patience as we work diligently to bring you this groundbreaking resource. In the meantime, we're committed to dramatically enhancing our free content offerings, giving you even more valuable health information at your fingertips.

Expanding Our Reach to Elite Levels

The release of my innovative book, " Your Guide to Cellular Health: Unlocking the Science of Longevity and Joy," coupled with the groundbreaking technical advancements of the upcoming Mercola Health Coach, is expected to skyrocket our site traffic. We anticipate becoming the most visited health sites globally, far surpassing our current traffic.

This remarkable growth would place us among the most visited websites globally. Looking ahead, we're setting our sights even higher, with the ambitious goal of eventually breaking into the top most visited sites worldwide. This vision reflects our commitment to making reliable, cutting-edge health information accessible to an ever-growing global audience.

The Future of Health Education: Our Vision for 2025 and Beyond

For decades, we've been privileged to help hundreds of millions with their health journey. Now, we're aiming higher. This forum upgrade marks one of our important major steps towards that goal, promising to usher in a new era of health education and community support. Stay tuned for updates as we work tirelessly to bring you this game-changing platform!